FADI AL-KHAYER: Open Payments
NPI 1861477069 · STORRS, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$89,914 in 133 payments from 11 companies in 2025. Trend: 2023 $98,787 · 2024 $88,647 · 2025 $89,914
Speaker / faculty: $73,921Honoraria: $7,220Travel & lodging: $5,756Food & beverage: $3,013Education: $4
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 80 | $46,800 |
| Corcept Therapeutics | 30 | $25,000 |
| Novo Nordisk Inc | 14 | $17,845 |
| Xeris Pharmaceuticals, Inc. | 1 | $100 |
| Amgen Inc. | 2 | $40 |
| Insulet Corporation | 1 | $27 |
| Almatica Pharma LLC | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Intra-Sana Laboratories | 1 | $21 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $17 |
Products named: Korlym, Ozempic, MOUNJARO, RECORLEV, ZEPBOUND, Omnipod, TERIPARATIDE, TEPEZZA.
Industry payments across CT — which companies pay providers there.
